Literature DB >> 12634963

Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?

Sergi Vidal-Sicart1, Francesca Pons, Susana Puig, Marisa Ortega, Antonio Vilalta, Francisco Martín, Ramón Rull, Josep Ma Palou, Teresa Castel.   

Abstract

Scintigraphic identification of the sentinel lymph node is achievable in nearly all patients with malignant melanoma. However, in a very small number of cases the sentinel node fails to be detected, and sometimes recurrence appears during follow-up in patients who had previously tested negative for metastatic disease. The purpose of this study was to review our experience in order to isolate the reasons for erroneous sentinel lymph node identification. The evaluation involved 435 consecutive malignant melanoma patients with AJCC stages I and II (clinically negative nodes) and Breslow thickness >0.76 mm. Lymphoscintigraphy was performed the day before surgery by intradermal administration of technetium-99m labelled nanocolloid. Dynamic and static images were obtained. The sentinel node was intraoperatively identified with the aid of patent blue dye and a hand-held gamma probe. After removal, routine histopathological examination with haematoxylin-eosin (H-E) and immunohistochemistry with S 100 and HMB45 (IHC) were performed. In those patients who developed regional recurrences during follow-up, sentinel nodes were further evaluated by reverse transcriptase-polymerase chain reaction (RT-PCR). Lymphoscintigraphy visualised at least one sentinel node in 434 out of 435 patients (99.8%). Uptake in in-transit sentinel lymph nodes was observed in 32 patients (7.4%). During surgery, localisation and removal of sentinel nodes was successful in 430/435 patients (98.8%). A total of 790 sentinel lymph nodes were harvested, with a mean of 1.8 per patient. Routine histopathological examination with H-E or IHC revealed metastatic disease in 72 patients (16.8%). During a mean follow-up of 26 months, seven of those patients with a negative sentinel node developed regional lymph node metastases. In five of them RT-PCR was positive for micrometastases within the sentinel node. In conclusion, erroneous sentinel lymph node identification can be due to changes in the surgical team, difficult lymph node location or absence of a thorough histological study. Nevertheless, it is not possible to explain completely why, in a very small percentage of cases, the sentinel node is erroneously identified.

Entities:  

Mesh:

Year:  2002        PMID: 12634963     DOI: 10.1007/s00259-002-1051-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  11 in total

1.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

2.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

3.  Management of popliteal sentinel nodes in melanoma.

Authors:  Shawn T Steen; Hamed Kargozaran; Christopher J Moran; Myung Shin-Sim; Donald L Morton; Mark B Faries
Journal:  J Am Coll Surg       Date:  2011-03-26       Impact factor: 6.113

4.  Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.

Authors:  D Massi; S Puig; A Franchi; J Malvehy; S Vidal-Sicart; M González-Cao; G Baroni; S Ketabchi; J Palou; M Santucci
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

5.  Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?

Authors:  Sergi Vidal-Sicart; Francesca Pons; Silvia Fuertes; Antonio Vilalta; Ramón Rull; Susana Puig; Josep M Palou; Marisa Ortega; Teresa Castel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-03       Impact factor: 9.236

6.  The sentinel node in breast cancer: an update.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

7.  High nevus counts confer a favorable prognosis in melanoma patients.

Authors:  Simone Ribero; John R Davies; Celia Requena; Cristina Carrera; Daniel Glass; Ramon Rull; Sergi Vidal-Sicart; Antonio Vilalta; Lucia Alos; Virtudes Soriano; Pietro Quaglino; Victor Traves; Julia A Newton-Bishop; Eduardo Nagore; Josep Malvehy; Susana Puig; Veronique Bataille
Journal:  Int J Cancer       Date:  2015-04-11       Impact factor: 7.396

8.  Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities.

Authors:  Hiroyuki Miura; Shuichi Ono; Koichi Shibutani; Hiroko Seino; Fumiyasu Tsushima; Shinya Kakehata; Katsumi Hirose; Hiromasa Fujita; Akihisa Kakuta; Masahiko Aoki; Yoshiomi Hatayma; Hideo Kawaguchi; Mariko Sato; Yoshihiro Takai; Takahide Kaneko; Daisuke Sawamura
Journal:  Springerplus       Date:  2014-10-22

9.  Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET.

Authors:  Peter Brader; Kaitlyn Kelly; Sheng Gang; Jatin P Shah; Richard J Wong; Hedvig Hricak; Ronald G Blasberg; Yuman Fong; Ziv Gil
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

Review 10.  The sentinel node in breast cancer.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.